Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajax Vascular is a private U.S.-based cardiovascular device company focused on vascular disease, particularly peripheral vascular disease/peripheral artery disease. Publicly available sources describe the company as active, for-profit, seed-stage, and headquartered in Menlo Park, California. The company appears to have been backed by healthcare investors including New Enterprise Associates and Longitude Capital. Detailed product, pipeline, and regulatory information is not readily available from public sources, suggesting it has remained relatively low profile and likely early stage. Based on the available evidence, Ajax Vascular is best characterized as an early-stage medtech company developing device-based solutions for peripheral vascular indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajax Vascular.